PMC:7170368 / 4518-4628 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"155","span":{"begin":13,"end":21},"obj":"Species"},{"id":"164","span":{"begin":0,"end":12},"obj":"Disease"},{"id":"165","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"Tax:9606"},{"id":"A164","pred":"tao:has_database_id","subj":"164","obj":"MESH:D006973"},{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T40","span":{"begin":27,"end":35},"obj":"Disease"}],"attributes":[{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T48","span":{"begin":77,"end":98},"obj":"Chemical"},{"id":"T49","span":{"begin":94,"end":98},"obj":"Chemical"}],"attributes":[{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_35674"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments."}

{"project":"LitCovid-sentences","denotations":[{"id":"T39","span":{"begin":0,"end":110},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T14","span":{"begin":0,"end":12},"obj":"Phenotype"}],"attributes":[{"id":"A14","pred":"hp_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/HP_0000822"}],"text":"Hypertensive patients with COVID-19 were divided into two subgroups based on antihypertensive drug treatments."}